UPSC MainsMEDICAL-SCIENCE-PAPER-II20235 Marks
Q1.

Enlist the clinical features of dengue fever.

How to Approach

This question requires a detailed understanding of the clinical presentation of dengue fever. The answer should be structured to cover the different phases of the illness – febrile, critical, and recovery – and the associated symptoms in each phase. Emphasis should be placed on differentiating features that help in early diagnosis and management. A systematic approach, listing symptoms under each phase, will be most effective.

Model Answer

0 min read

Introduction

Dengue fever is a mosquito-borne viral infection that poses a significant public health challenge globally, particularly in tropical and subtropical regions. Caused by any of the four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4), the disease manifests with a wide spectrum of clinical presentations, ranging from asymptomatic infection to severe dengue with life-threatening complications. Early recognition of clinical features is crucial for timely management and reducing morbidity and mortality. The World Health Organization (WHO) revised the dengue classification in 2009 to focus on warning signs of progression to severe dengue.

Clinical Features of Dengue Fever

The clinical course of dengue fever is typically divided into three phases: febrile, critical, and recovery. Each phase is characterized by distinct clinical features.

1. Febrile Phase (2-7 days)

This phase is marked by the onset of fever and other systemic symptoms.

  • Fever: High-grade fever (40°C or 104°F) with sudden onset.
  • Headache: Severe frontal headache, often retro-orbital pain (pain behind the eyes).
  • Myalgia and Arthralgia: Prominent muscle and joint pain, giving rise to the nickname "breakbone fever."
  • Nausea and Vomiting: Common gastrointestinal symptoms.
  • Skin Rash: Maculopapular rash appearing 3-4 days after the onset of fever.
  • Minor Bleeding Manifestations: Petechiae (small red spots on the skin), epistaxis (nosebleeds), gingival bleeding (bleeding gums).
  • Leukopenia: Decreased white blood cell count.

2. Critical Phase (24-48 hours)

This is the most dangerous phase, typically occurring around days 3-7 of illness. Plasma leakage leads to potentially life-threatening complications.

  • Plasma Leakage: Increased capillary permeability leading to fluid accumulation in body cavities (pleural effusion, ascites).
  • Severe Abdominal Pain: Intense and persistent abdominal pain.
  • Persistent Vomiting: Frequent and unrelenting vomiting.
  • Clinical Signs of Shock: Restlessness, irritability, cold and clammy skin, weak pulse, hypotension (low blood pressure).
  • Severe Bleeding: Gastrointestinal bleeding (hematemesis, melena), vaginal bleeding, bleeding from injection sites.
  • Hepatomegaly: Enlargement of the liver, often tender to palpation.
  • Thrombocytopenia: Significantly decreased platelet count (<100,000/µL).
  • Increased Hematocrit: Due to hemoconcentration from plasma leakage.

3. Recovery Phase (2-3 days)

This phase marks the gradual resolution of symptoms and restoration of fluid balance.

  • Gradual Improvement of Symptoms: Fever subsides, and general well-being improves.
  • Reabsorption of Fluid: Fluid accumulated in body cavities is gradually reabsorbed.
  • Bradycardia: Slow heart rate.
  • Rash: A confluent, itchy rash may appear, often described as "islands of white in a sea of red."
  • Platelet Count Recovery: Platelet count begins to rise.
  • Diuresis: Increased urine output as fluid balance is restored.

Severe Dengue: A subset of dengue cases develops into severe dengue, characterized by any of the following:

  • Dengue shock syndrome (DSS)
  • Severe bleeding
  • Severe organ impairment (liver, kidneys, brain)
Phase Key Features Warning Signs
Febrile High fever, headache, myalgia, rash Severe abdominal pain, persistent vomiting
Critical Plasma leakage, shock, severe bleeding Worsening abdominal pain, lethargy, bleeding from gums or nose
Recovery Improvement in symptoms, fluid reabsorption Bradycardia, rash

Conclusion

Dengue fever presents with a dynamic clinical picture, evolving through distinct phases. Recognizing the clinical features, particularly the warning signs of the critical phase, is paramount for prompt medical intervention. Effective management relies on early diagnosis, fluid resuscitation, and close monitoring of vital signs and hematological parameters. Continued research and public health initiatives are essential to control dengue transmission and reduce its burden globally.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Petechiae
Small, pinpoint-sized red or purple spots on the skin caused by capillary bleeding.
Hemoconcentration
An increase in the concentration of red blood cells in the blood due to a decrease in plasma volume, often seen in dengue shock syndrome.

Key Statistics

According to the WHO, an estimated 100-400 million dengue infections occur worldwide each year.

Source: World Health Organization (WHO), 2023 (Knowledge Cutoff: Dec 2023)

Southeast Asia bears the greatest burden of dengue fever, accounting for approximately 70% of the global cases.

Source: PLOS Neglected Tropical Diseases, 2019 (Knowledge Cutoff: Dec 2023)

Examples

Dengue outbreak in Delhi, 2023

In 2023, Delhi witnessed a significant surge in dengue cases, with over 9,000 cases reported by November, highlighting the vulnerability of urban areas to dengue transmission.

Frequently Asked Questions

What is the role of NS1 antigen testing in dengue diagnosis?

NS1 antigen is a viral protein detectable in the early stages of dengue infection (first few days). NS1 antigen testing is a rapid diagnostic test that can aid in early diagnosis, particularly when viral RNA detection (PCR) is not readily available.

Topics Covered

MedicineInfectious DiseasesDengueViral InfectionsTropical Diseases